MAPT and Alzheimer disease: Additionally, intravenous injection of outer membrane vesicles derived from AD patients into healthy mice for eight weeks increases the BBB permeability with elevated levels of brain inflammatory markers, glial cell activation, tau hyperphosphorylation, and cognitive impairment in the recipient mice [143].